Novavax IncNASDAQ:NVAX
- LAST PRICE4.0400
- TODAY'S CHANGE (%)-0.0800 (-1.9417%)
- Bid / Lots4.0400/ 16
- Ask / Lots4.0500/ 39
- Open / Previous Close4.0700 / 4.1200
- Day Range
- 52 Week Range
- Volume1,621,061
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVAX |
|---|---|---|
| 09:32 ET | 108415 | 4.03 |
| 09:34 ET | 14156 | 4.055 |
| 09:36 ET | 13897 | 4.045 |
| 09:38 ET | 12935 | 4.04 |
| 09:39 ET | 26926 | 4.05 |
| 09:41 ET | 8443 | 4.055 |
| 09:43 ET | 16453 | 4.0412 |
| 09:45 ET | 22982 | 4.0491 |
| 09:48 ET | 35802 | 4.045 |
| 09:50 ET | 50497 | 4.04 |
| 09:52 ET | 20858 | 4.06 |
| 09:54 ET | 13222 | 4.05 |
| 09:56 ET | 24663 | 4.065 |
| 09:57 ET | 11715 | 4.075 |
| 09:59 ET | 8629 | 4.095 |
| 10:01 ET | 17991 | 4.0903 |
| 10:03 ET | 21075 | 4.08 |
| 10:06 ET | 32303 | 4.08 |
| 10:08 ET | 9228 | 4.06 |
| 10:10 ET | 26135 | 4.045 |
| 10:12 ET | 11416 | 4.05 |
| 10:14 ET | 15483 | 4.065 |
| 10:15 ET | 21683 | 4.08 |
| 10:17 ET | 13011 | 4.085 |
| 10:19 ET | 1675 | 4.085 |
| 10:21 ET | 18205 | 4.095 |
| 10:24 ET | 19651 | 4.08 |
| 10:26 ET | 4866 | 4.06 |
| 10:28 ET | 3791 | 4.06 |
| 10:30 ET | 10841 | 4.065 |
| 10:32 ET | 7002 | 4.04 |
| 10:33 ET | 20513 | 4.04 |
| 10:35 ET | 3980 | 4.05 |
| 10:37 ET | 10787 | 4.035 |
| 10:39 ET | 4464 | 4.03 |
| 10:42 ET | 68658 | 4.067 |
| 10:44 ET | 7612 | 4.055 |
| 10:46 ET | 11552 | 4.055 |
| 10:48 ET | 11434 | 4.0501 |
| 10:50 ET | 22973 | 4.07 |
| 10:51 ET | 3301 | 4.065 |
| 10:53 ET | 4794 | 4.0516 |
| 10:55 ET | 4616 | 4.04 |
| 10:57 ET | 15775 | 4.06 |
| 11:00 ET | 11653 | 4.07 |
| 11:02 ET | 3789 | 4.07 |
| 11:04 ET | 10534 | 4.075 |
| 11:06 ET | 5074 | 4.06 |
| 11:08 ET | 4910 | 4.06 |
| 11:09 ET | 5410 | 4.065 |
| 11:11 ET | 18439 | 4.075 |
| 11:13 ET | 9598 | 4.07 |
| 11:15 ET | 6040 | 4.07 |
| 11:18 ET | 8185 | 4.07 |
| 11:20 ET | 4152 | 4.06 |
| 11:22 ET | 3934 | 4.05 |
| 11:24 ET | 16524 | 4.055 |
| 11:26 ET | 2731 | 4.055 |
| 11:27 ET | 2826 | 4.05 |
| 11:29 ET | 6375 | 4.055 |
| 11:31 ET | 14153 | 4.055 |
| 11:33 ET | 2700 | 4.05 |
| 11:36 ET | 14478 | 4.06 |
| 11:38 ET | 9145 | 4.05 |
| 11:40 ET | 9430 | 4.05 |
| 11:42 ET | 23426 | 4.05 |
| 11:44 ET | 4710 | 4.04 |
| 11:45 ET | 4290 | 4.04 |
| 11:47 ET | 16810 | 4.035 |
| 11:49 ET | 32326 | 4.04 |
| 11:51 ET | 18544 | 4.0568 |
| 11:54 ET | 13802 | 4.05 |
| 11:56 ET | 2412 | 4.05 |
| 11:58 ET | 17984 | 4.04 |
| 12:00 ET | 12262 | 4.0473 |
| 12:02 ET | 4572 | 4.0406 |
| 12:03 ET | 5021 | 4.03 |
| 12:05 ET | 10427 | 4.03 |
| 12:07 ET | 2911 | 4.035 |
| 12:09 ET | 6673 | 4.035 |
| 12:12 ET | 6194 | 4.03 |
| 12:14 ET | 10030 | 4.035 |
| 12:16 ET | 5148 | 4.035 |
| 12:18 ET | 1252 | 4.035 |
| 12:20 ET | 11923 | 4.03 |
| 12:21 ET | 4830 | 4.035 |
| 12:23 ET | 3841 | 4.035 |
| 12:25 ET | 2679 | 4.035 |
| 12:27 ET | 9276 | 4.035 |
| 12:30 ET | 5407 | 4.035 |
| 12:32 ET | 23954 | 4.03 |
| 12:34 ET | 4445 | 4.0339 |
| 12:36 ET | 17041 | 4.04 |
| 12:38 ET | 7124 | 4.035 |
| 12:39 ET | 4672 | 4.035 |
| 12:41 ET | 6442 | 4.05 |
| 12:43 ET | 4307 | 4.04 |
| 12:45 ET | 4127 | 4.03 |
| 12:48 ET | 8017 | 4.035 |
| 12:50 ET | 9702 | 4.04 |
| 12:52 ET | 14010 | 4.05 |
| 12:54 ET | 2482 | 4.05 |
| 12:56 ET | 2732 | 4.05 |
| 12:57 ET | 3465 | 4.05 |
| 12:59 ET | 9912 | 4.05 |
| 01:01 ET | 2589 | 4.05 |
| 01:03 ET | 14910 | 4.04 |
| 01:06 ET | 522 | 4.04 |
| 01:08 ET | 1928 | 4.04 |
| 01:10 ET | 8963 | 4.04 |
| 01:12 ET | 13765 | 4.04 |
| 01:14 ET | 9420 | 4.045 |
| 01:15 ET | 1713 | 4.04 |
| 01:17 ET | 1663 | 4.04 |
| 01:19 ET | 2019 | 4.04 |
| 01:21 ET | 10750 | 4.04 |
| 01:24 ET | 1951 | 4.045 |
| 01:26 ET | 766 | 4.04 |
Today
Yesterday
Shah Capital nominates two highly qualified independent director candidates for Novavax, from 6:00AM ET on Monday Apr 15, 2024 by Dow Jones
6:00AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 11, 2024
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement, from 12:32PM ET on Thursday Apr 11, 2024 by Dow Jones
12:32PM ET on Thursday Apr 11, 2024 by Dow Jones
Apr 9, 2024
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement, from 12:31PM ET on Tuesday Apr 09, 2024 by Dow Jones
12:31PM ET on Tuesday Apr 09, 2024 by Dow Jones
Apr 4, 2024
Levi & Korsinsky, LLP Notifies Shareholders of Novavax, Inc. (NVAX) an Upcoming Claims Deadline in a Class Action Settlement, from 12:21PM ET on Thursday Apr 04, 2024 by Dow Jones
12:21PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novavax Inc | 576.6M | -0.7x | --- |
PTC Therapeutics Inc | 2.0B | -3.1x | --- |
P3 Health Partners Inc | 155.7M | -0.7x | --- |
Inotiv Inc | 145.2M | -4.3x | --- |
Sinovac Biotech Ltd | 639.9M | -1.8x | +15.89% |
Invitae Corp | 229.2K | 0.0x | --- |
Company Information
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Contact Information
- Headquarters
- 700 Quince Orchard RoadGAITHERSBURG, MD, United States 20878
- Phone
- 240-268-2000
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- James Young
- President, Chief Executive Officer, Director
- John Jacobs
- President, Chief Operating Officer
- John Trizzino
- Chief Financial Officer, Executive Vice President, Treasurer
- James Kelly
- President, Research and Development
- Filip Dubovsky
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $576.6M |
|---|---|
Revenue (TTM) | $983.7M |
Shares Outstanding | 140.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.63 |
EPS | $-5.53 |
Book Value | $-5.14 |
P/E Ratio | -0.7x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -57.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
